ACS Medicinal Chemistry Letters
Letter
D. J. ABT-888, an Orally Active poly(ADP-ribose) Polymerase
Inhibitor That Potentiates DNA-damaging Agents in Preclinical
Tumor Models. Clin. Cancer Res. 2007, 13, 2728−2737.
(5) Chen, B.; Dodge, M. E.; Tang, W.; Lu, J.; Ma, Z.; Fan, C.-W.;
Wei, S.; Hao, W.; Kilgore, J.; Williams, N. S.; Roth, M. G.; Amatruda,
J. F.; Chen, C.; Lum, L. Small Molecule-mediated Disruption of Wnt-
dependent Signaling in Tissue Regeneration and Cancer. Nat. Chem.
Biol. 2009, 5, 100−107.
(6) Lau, T.; Chan, E.; Callow, M.; Waaler, J.; Boggs, J.; Blake, R. A.;
Magnuson, S.; Sambrone, A.; Schutten, M.; Firestein, R.; Machon, O.;
Korinek, V.; Choo, E.; Diaz, D.; Merchant, M.; Polakis, P.; Holsworth,
D. D.; Krauss, S.; Costa, M. A Novel Tankyrase Small-molecule
Inhibitor Suppresses APC Mutation-driven Colorectal Tumor
Growth. Cancer Res. 2013, 73, 3132−3144.
(7) Johannes, J. W.; Almeida, L.; Barlaam, B.; Boriack-Sjodin, P. A.;
Casella, R.; Croft, R. A.; Dishington, A. P.; Gingipalli, L.; Gu, C.;
Hawkins, J. L.; Holmes, J. L.; Howard, T.; Huang, J.; Ioannidis, S.;
Kazmirski, S.; Lamb, M. L.; McGuire, T. M.; Moore, J. E.; Ogg, D.;
Patel, A.; Pike, K. G.; Pontz, T.; Robb, G. R.; Su, N.; Wang, H.; Wu,
X.; Zhang, H.-J.; Zhang, Y.; Zheng, X.; Wang, T. Pyrimidinone
Nicotinamide Mimetics as Selective Tankyrase and Wnt Pathway
Inhibitors Suitable for in Vivo Pharmacology. ACS Med. Chem. Lett.
2015, 6, 254−259.
Proliferation and Tumorigenesis by Alleviating Replication Stress.
Nucleic Acids Res. 2018, 46, 8908−8916.
(19) Yu, M.; Schreek, S.; Cerni, C.; Schamberger, C.; Lesniewicz, K.;
̈
Poreba, E.; Vervoorts, J.; Walsemann, G.; Grotzinger, J.; Kremmer, E.;
Mehraein, Y.; Mertsching, J.; Kraft, R.; Austen, M.; Luscher-Firzlaff, J.;
Luscher, B. PARP-10, a Novel Myc-interacting Protein with
̈
̈
poly(ADP-ribose) Polymerase Activity, Inhibits Transformation.
Oncogene 2005, 24, 1982−1993.
(20) Zhao, Y.; Hu, X.; Wei, L.; Song, D.; Wang, J.; You, L.; Saiyin,
H.; Li, Z.; Yu, W.; Yu, L.; Ding, J.; Wu, J. PARP10 Suppresses Tumor
Metastasis through Regulation of Aurora A Activity. Oncogene 2018,
37, 2921−2935.
(21) Venkannagari, H.; Fallarero, A.; Feijs, K. L. H.; Luscher, B.;
̈
̈
Lehtio, L. Activity-based Assay for Human mono-ADP-ribosyltrans-
ferases ARTD7/PARP15 and ARTD10/PARP10 Aimed at Screening
and Profiling Inhibitors. Eur. J. Pharm. Sci. 2013, 49, 148−156.
(22) Morgan, R. K.; Cohen, M. S. A Clickable Aminooxy Probe for
Monitoring Cellular ADP-Ribosylation. ACS Chem. Biol. 2015, 10,
1778−1784.
(23) Gibson, B. A.; Zhang, Y.; Jiang, H.; Hussey, K. M.; Shrimp, J.
H.; Lin, H.; Schwede, F.; Yu, Y.; Kraus, W. L. Chemical Genetic
Discovery of PARP Targets Reveals a Role for PARP-1 in
Transcription Elongation. Science 2016, 353, 45−50.
(24) Suto, M. J.; Turner, W. R.; Arundel-Suto, C. M.; Werbel, L. M.;
Sebolt-Leopold, J. S. Dihydroisoquinolinones: The Design and
Synthesis of a New Series of Potent Inhibitors of poly(ADP-ribose)
Polymerase. Anti-Cancer Drug Des. 1991, 6, 107−117.
(8) Kirby, I. T.; Cohen, M. S. Small-Molecule Inhibitors of PARPs:
From Tools for Investigating ADP-Ribosylation to Therapeutics.
Current Topics in Microbioogy and Immunology; Springer: Berlin,
̈
(9) Peng, B.; Thorsell, A.-G.; Karlberg, T.; Schuler, H.; Yao, S. Q.
Small Molecule Microarray Based Discovery of PARP14 Inhibitors.
Angew. Chem., Int. Ed. 2017, 56, 248−253.
(25) Ferraris, D. V. Evolution of poly(ADP-ribose) Polymerase-1
(PARP-1) Inhibitors. From Concept to Clinic. J. Med. Chem. 2010,
53, 4561−4584.
(26) Morgan, R. K.; Carter-O’Connell, I.; Cohen, M. S. Selective
Inhibition of PARP10 Using a Chemical Genetics Strategy. Bioorg.
Med. Chem. Lett. 2015, 25, 4770−4773.
(10) Yoneyama-Hirozane, M.; Matsumoto, S.-I.; Toyoda, Y.;
Saikatendu, K. S.; Zama, Y.; Yonemori, K.; Oonishi, M.; Ishii, T.;
Kawamoto, T. Identification of PARP14 Inhibitors Using Novel
Methods for Detecting Auto-ribosylation. Biochem. Biophys. Res.
Commun. 2017, 486, 626−631.
(27) Pinto, A. F.; Schuler, H. Comparative Structural Analysis of the
̈
Putative mono-ADP-ribosyltransferases of the ARTD/PARP Family.
Curr. Top. Microbiol. Immunol. 2014, 384, 153−166.
(11) Ekblad, T.; Lindgren, A. E. G.; Andersson, C. D.; Caraballo, R.;
(28) Kurouchi, H.; Sumita, A.; Otani, Y.; Ohwada, T. Protonation
Switching to the Least-basic Heteroatom of Carbamate through
Cationic Hydrogen Bonding Promotes the Formation of Isocyanate
Cations. Chem. - Eur. J. 2014, 20, 8682−8690.
Thorsell, A.-G.; Karlberg, T.; Spjut, S.; Linusson, A.; Schuler, H.;
̈
Elofsson, M. Towards Small Molecule Inhibitors of mono-ADP-
ribosyltransferases. Eur. J. Med. Chem. 2015, 95, 546−551.
(12) Venkannagari, H.; Verheugd, P.; Koivunen, J.; Haikarainen, T.;
(29) Jiang, H.; Kim, J. H.; Frizzell, K. M.; Kraus, W. L.; Lin, H.
Clickable NAD Analogues for Labeling Substrate Proteins of
poly(ADP-ribose) Polymerases. J. Am. Chem. Soc. 2010, 132, 9363−
9372.
(30) Carter-O’Connell, I.; Jin, H.; Morgan, R. K.; David, L. L.;
Cohen, M. S. Engineering the Substrate Specificity of ADP-
ribosyltransferases for Identifying Direct Protein Targets. J. Am.
Chem. Soc. 2014, 136, 5201−5204.
(31) Murthy, S.; Desantis, J.; Verheugd, P.; Maksimainen, M. M.;
Venkannagari, H.; Massari, S.; Ashok, Y.; Obaji, E.; Nkizinkinko, Y.;
Obaji, E.; Ashok, Y.; Narwal, M.; Pihlajaniemi, T.; Luscher, B.; Lehtio,
̈
̈
L. Small-Molecule Chemical Probe Rescues Cells from Mono-ADP-
Ribosyltransferase ARTD10/PARP10-Induced Apoptosis and Sensi-
tizes Cancer Cells to DNA Damage. Cell Chem. Biol. 2016, 23, 1251−
1260.
(13) Upton, K.; Meyers, M.; Thorsell, A.-G.; Karlberg, T.; Holechek,
̈
J.; Lease, R.; Schey, G.; Wolf, E.; Lucente, A.; Schuler, H.; Ferraris, D.
Design and Synthesis of Potent Inhibitors of the mono(ADP-
ribosyl)transferase, PARP14. Bioorg. Med. Chem. Lett. 2017, 27,
2907−2911.
Luscher, B.; Tabarrini, O.; Lehtio, L. 4-(Phenoxy) and 4-(benzyloxy)-
̈
̈
benzamides as Potent and Selective Inhibitors of mono-ADP-
ribosyltransferase PARP10/ARTD10. Eur. J. Med. Chem. 2018, 156,
93−102.
(14) Holechek, J.; Lease, R.; Thorsell, A.-G.; Karlberg, T.;
McCadden, C.; Grant, R.; Keen, A.; Callahan, E.; Schuler, H.;
̈
Ferraris, D. Design, Synthesis and Evaluation of Potent and Selective
Inhibitors of mono-(ADP-ribosyl)transferases PARP10 and PARP14.
Bioorg. Med. Chem. Lett. 2018, 28, 2050−2054.
(15) Nicolae, C. M.; Aho, E. R.; Vlahos, A. H. S.; Choe, K. N.; De,
S.; Karras, G. I.; Moldovan, G.-L. The ADP-ribosyltransferase
PARP10/ARTD10 Interacts with Proliferating Cell Nuclear Antigen
(PCNA) and Is Required for DNA Damage Tolerance. J. Biol. Chem.
2014, 289, 13627−13637.
(16) Verheugd, P.; Forst, A. H.; Milke, L.; Herzog, N.; Feijs, K. L.
H.; Kremmer, E.; Kleine, H.; Luscher, B. Regulation of NF-κB
̈
Signalling by the mono-ADP-ribosyltransferase ARTD10. Nat.
Commun. 2013, 4, 1683.
(17) Vyas, S.; Chang, P. New PARP Targets for Cancer Therapy.
Nat. Rev. Cancer 2014, 14, 502−509.
(18) Schleicher, E. M.; Galvan, A. M.; Imamura-Kawasawa, Y.;
Moldovan, G.-L.; Nicolae, C. M. PARP10 Promotes Cellular
F
ACS Med. Chem. Lett. XXXX, XXX, XXX−XXX